WCLC 2020
IASLC World Conference On Lung Cancer
January 28-31, 2021 |
Virtual
Improvement of lung cancer management and care with the victorian lung cancer registry
Monitoring biomarkers in non-small cell lung cancer patients treated with immune checkpoint inhibitors
Lung cancer in the evolving field of precision medicine
Artificial intelligence platforms enable population-wide lung cancer screening programs
Neoadjuvant singular immunotherapy versus perioperative chemoimmunotherapy for early-stage lung cancer
Osimertinib significantly improved disease-free survival in patients with resected EGFR-mutated non-small cell lung cancer, regardless of adjuvant chemotherapy use
The first ever phase 3, placebo-controlled study of nivolumab in relapsed malignant mesothelioma CONFIRMed its survival benefits
Applying low-dose computerized tomography for lung cancer screening in Taiwan